It is postulated that gastrointestinal (GI) endoscopy is contraindicated in patients with suspected perforated ulcer. But in some hospitals outside the United States, upper GI endoscopy is performed ...

Background and Aims: Because non-bleeding visible vessels (NBVV) of gastric peptic ulcers have the potential to re-bleed, endoscopic hemostatic treatment may be necessary during the first emergency ...

A new study shows that elderly patients who underwent endoscopy within one day of presentation for peptic ulcer bleeding had a two-day shorter hospital stay and were less likely to require upper ...

The benefit of routine repeat endoscopy after endoscopic hemostasis in the management of peptic ulcer bleeding is controversial. The aim of this Review is to evaluate the efficacy of second-look ...

Please provide your email address to receive an email when new articles are posted on . Achieving endoscopic remission may be difficult for patients with Crohn’s disease with larger and deep ulcers in ...

The American College of Gastroenterology published updated guidelines on managing upper gastrointestinal and ulcer bleeding in the May 2021 issue of The American Journal of Gastroenterology. The ...

The appearance of a peptic ulcer on endoscopy can give important prognostic information and influence the decision as to whether endoscopic therapy or medical treatment is required. Although the best ...

Stomach ulcers, also known as gastric ulcers, are painful sores that develop in the lining of the stomach or the first part of the small intestine. These ulcers can be caused by factors such as ...

A therapeutic endoscopic procedure provides treatment that is carried out via the endoscope. A procedure, which starts as a diagnostic or screening endoscopy, may become a therapeutic endoscopy ...

Proton-pump inhibitor esomeprazole achieved similar success of hemostasis whether administered orally or intravenously in patients with peptic ulcer bleeding after endoscopy, according to research ...

CHAPEL HILL, N.C.--(BUSINESS WIRE)-- POZEN Inc. (NASDAQ: POZN) announced today that the U.S. Food and Drug Administration (FDA) has completed its internal discussions and informed the Company that ...